AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
AVEO Oncology (AVEO) - Total liabilities
Total liabilities on the balance sheet as of September 2022 : $72.38 M
According to AVEO Oncology 's latest financial reports the company's total liabilities are $72.38 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2021-12-31 | $59.47 M | 88.09% |
| 2020-12-31 | $31.61 M | -11.57% |
| 2019-12-31 | $35.75 M | -35.18% |
| 2018-12-31 | $55.16 M | -39.36% |
| 2017-12-31 | $90.96 M | 211.42% |
| 2016-12-31 | $29.2 M | 25.28% |
| 2015-12-31 | $23.31 M | -53.42% |
| 2014-12-31 | $50.05 M | -34.49% |
| 2013-12-31 | $76.4 M | -13.69% |
| 2012-12-31 | $88.53 M | 23.8% |
| 2011-12-31 | $71.5 M | -9.8% |
| 2010-12-31 | $79.27 M | 10.15% |
| 2009-12-31 | $71.97 M | -57.36% |
| 2008-12-31 | $0.16 B | 1.6% |
| 2007-12-31 | $0.16 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $53.14 B | 73,313.55% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 125,503.69% | 🇺🇸 USA |
 Biogen BIIB | $12.04 B | 16,540.05% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $7.10 B | 9,718.06% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 90,624.98% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.44 M | -99.39% | 🇺🇸 USA |